1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. FRACTYL HEALTH INC.
Fractyl Health Inc.
XNAS: GUTS
Download real time
0.81 -0.04 (-4.71%)
66.80% Fall from 52W High
1.4M
XNAS Volume
High vol. this week

XNAS 17 Jul, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Fractyl Health Inc

The latest disclosure was made by Ajay Royan in Fractyl Health Inc where a trade of 23,000 Common Stock done at an average price of $0.9 was reported to US exchanges on June 12, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ajay Royan Director Purchase of securities on an exchange or from another person at price $ 0.85 per share. 12 Jun 2026 23,000 40,901 - 0.9 19,596 Common Stock
Christopher Thompson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2026 22,500 22,500 - - Stock Option
Samuel Conaway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2026 22,500 22,500 - - Stock Option
Kelly Ann Barnes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2026 22,500 22,500 - - Stock Option
Harith Rajagopalan Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.73 per share. 10 Jun 2026 25,000 540,557 - 0.7 18,253 Common Stock
Ajay Royan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2026 22,500 22,500 - - Stock Option
Marc Elia Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2026 22,500 22,500 - - Stock Option
Clive A. Meanwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2026 22,500 22,500 - - Stock Option
Lara Smith-Weber Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.69 per share. 08 Jun 2026 20,000 20,000 - 0.7 13,708 Common Stock
Lara Smith-Weber Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jan 2026 1,036,800 1,036,800 - - Stock Option
Sarah Toomey General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2025 743,913 743,913 - - Stock Option (right to buy)
Harith Rajagopalan Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2025 2,486,302 2,486,302 - - Stock Option (right to buy)
Jay D. Caplan President, Chief Product Off. Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2025 845,226 845,226 - - Stock Option (right to buy)
Harith Rajagopalan Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.92 per share. 04 Dec 2025 10,416 501,745 - 1.9 19,999 Common Stock
Christopher Thompson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Sep 2025 45,000 45,000 - - Stock Option
Amy W. Schulman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 22,500 22,500 - - Stock Option
Clive A. Meanwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 22,500 22,500 - - Stock Option
Marc Elia Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 22,500 22,500 - - Stock Option
Kelly Ann Barnes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 22,500 22,500 - - Stock Option
Samuel Conaway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 22,500 22,500 - - Stock Option
Ajay Royan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 22,500 22,500 - - Stock Option
Kelly Ann Barnes Director Purchase of securities on an exchange or from another person at price $ 1.30 per share. 14 Mar 2025 31,000 31,000 - 1.3 40,210 Common Stock
Ajay Royan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.28 per share. 14 Mar 2025 17,901 17,901 - 1.3 22,980 Common Stock
Amy W. Schulman Director Purchase of securities on an exchange or from another person at price $ 1.17 per share. 13 Mar 2025 8,550 8,550 - 1.2 9,964 Common Stock
Samuel Conaway Director Purchase of securities on an exchange or from another person at price $ 1.17 per share. 13 Mar 2025 8,550 8,550 - 1.2 9,964 Common Stock
Lisa A. Davidson Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 174,700 174,700 - - Stock Option (right to buy)
Jay D. Caplan President, Chief Product Off. Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 104,400 104,400 - - Stock Option (right to buy)
Jay D. Caplan President, Chief Product Off. Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 179,700 179,700 - - Stock Option (right to buy)
Harith Rajagopalan Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 571,491 571,491 - - Stock Option (right to buy)
Harith Rajagopalan Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 261,540 261,540 - - Stock Option (right to buy)
Lisa A. Davidson Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 91,500 91,500 - - Stock Option (right to buy)
Timothy Kieffer Chief Scientific Officer 27 Feb 2025 35,280 35,280 - - Stock Option (right to buy)
Timothy Kieffer Chief Scientific Officer 27 Feb 2025 169,700 169,700 - - Stock Option (right to buy)
Sarah Toomey General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 166,200 166,200 - - Stock Option (right to buy)
Sarah Toomey General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 79,380 79,380 - - Stock Option (right to buy)
Jay D. Caplan President, Chief Product Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2025 22,346 17,924 - - Stock Option
Harith Rajagopalan Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2025 90,972 11,564 - - Stock Option
Harith Rajagopalan Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2025 20,948 102,536 - - Stock Option
Harith Rajagopalan Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 1.82 per share. 30 Jan 2025 90,972 491,329 - 1.8 165,205 Common Stock
Harith Rajagopalan Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. 30 Jan 2025 90,972 582,301 - 1.7 154,652 Common Stock
Harith Rajagopalan Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 1.95 per share. 30 Jan 2025 20,948 491,329 - 1.9 40,798 Common Stock
Harith Rajagopalan Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. 30 Jan 2025 20,948 512,277 - 1.7 35,612 Common Stock
Jay D. Caplan President, Chief Product Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2025 21,472 40,270 - - Stock Option
Jay D. Caplan President, Chief Product Off. Sale of securities on an exchange or to another person at price $ 1.81 per share. 30 Jan 2025 22,346 153,544 - 1.8 40,464 Common Stock
Jay D. Caplan President, Chief Product Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. 30 Jan 2025 22,346 175,890 - 1.7 37,988 Common Stock
Jay D. Caplan President, Chief Product Off. Sale of securities on an exchange or to another person at price $ 1.95 per share. 30 Jan 2025 21,472 153,544 - 1.9 41,802 Common Stock
Jay D. Caplan President, Chief Product Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. 30 Jan 2025 21,472 175,016 - 1.7 36,502 Common Stock
Harith Rajagopalan Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 2.47 per share. 10 Nov 2024 96,517 491,329 - 2.5 238,358 Common Stock
Harith Rajagopalan Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Nov 2024 216,924 0 - - Restricted Stock Units
Harith Rajagopalan Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Nov 2024 216,924 587,846 - 0 Common Stock
Jay D. Caplan President, Chief Product Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Nov 2024 187,257 0 - - Restricted Stock Unit
Jay D. Caplan President, Chief Product Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Nov 2024 187,257 217,741 - 0 Common Stock
Jay D. Caplan President, Chief Product Off. Sale of securities on an exchange or to another person at price $ 2.47 per share. 10 Nov 2024 64,197 153,544 - 2.5 158,541 Common Stock
Jay D. Caplan President, Chief Product Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. 12 Sep 2024 95,484 95,484 - 1.7 162,323 Common Stock
Jay D. Caplan President, Chief Product Off. Sale of securities on an exchange or to another person at price $ 2.90 per share. 12 Sep 2024 65,000 30,484 - 2.9 188,474 Common Stock
Jay D. Caplan President, Chief Product Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Sep 2024 95,484 0 - - Stock Option
Adrian Kimber Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 250,000 250,000 - - Stock Option
Clive A. Meanwell Director 06 Feb 2024 596,352 0 - - Series F Preferred Stock
Clive A. Meanwell Director 06 Feb 2024 277,890 277,890 - - Common Stock
Jay D. Caplan President, Chief Product Off. 06 Feb 2024 177,726 0 - - Series B Preferred Stock
Jay D. Caplan President, Chief Product Off. 06 Feb 2024 50,000 0 - - Series A Preferred Stock
Jay D. Caplan President, Chief Product Off. 06 Feb 2024 32,514 0 - - Series C-2 Preferred Stock
Jay D. Caplan President, Chief Product Off. 06 Feb 2024 44,730 0 - - Series C-1 Preferred Stock
Jay D. Caplan President, Chief Product Off. 06 Feb 2024 118,810 118,810 - - Common Stock
Jay D. Caplan President, Chief Product Off. 06 Feb 2024 23,299 358,806 - - Common Stock
Marc Elia Director 06 Feb 2024 2,981,763 0 - - Series F Preferred Stock
Marc Elia Director 06 Feb 2024 1,389,451 1,389,451 - - Common Stock
Marc Elia Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 06 Feb 2024 466,666 1,856,117 - 15 6,999,990 Common Stock
Ajay Royan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 15.00 per share. 06 Feb 2024 333,333 1,251,900 - 15 4,999,995 Common Stock
Ajay Royan Director, Ten Percent Owner 06 Feb 2024 4,025,764 0 - - Series C-1 Preferred Stock
Ajay Royan Director, Ten Percent Owner 06 Feb 2024 6,502,796 0 - - Series C-2 Preferred Stock
Ajay Royan Director, Ten Percent Owner 06 Feb 2024 545,450 0 - - Series D Preferred Stock
Ajay Royan Director, Ten Percent Owner 06 Feb 2024 918,567 918,567 - - Common Stock
Ajay Royan Director, Ten Percent Owner 06 Feb 2024 5,160,301 5,160,301 - - Common Stock
Ajay Royan Director, Ten Percent Owner 06 Feb 2024 1,598,225 0 - - Series F Preferred Stock
Ajay Royan Director, Ten Percent Owner 06 Feb 2024 373,021 0 - - Series E Preferred Stock
Amy W. Schulman Director 01 Feb 2024 45,000 45,000 - - Stock Option
Clive A. Meanwell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 45,000 45,000 - - Stock Option
Marc Elia Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 45,000 45,000 - - Stock Option
Ajay Royan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 45,000 45,000 - - Stock Option
Kelly Ann Barnes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 45,000 45,000 - - Stock Option
Samuel Conaway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 45,000 45,000 - - Stock Option
Allan R. Will Director 01 Feb 2024 45,000 45,000 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters